Takeda Pharmaceutical Company Limited (TAK) — 分析师展望 / 分析师共识目标价为. 基于 6 位分析师评级, 共识为 看涨 — 5 买入, 1 持有.
分析师预估 每股收益(EPS)为 $0.28 和 营收为 $25.85B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $34.17 vs 预期 $0.28 (超预期 +12087.2%). 分析师准确度: 1%.
TAK 分析师评级
Buy
基于过去3个月内 6 位分析师对 Takeda Pharmaceutical Company Limited 的评级
EPS 预测 — TAK
1%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $34.17
vs Est $0.28
▲ 99.2% off
Profitability Outlook
Company is profitable but with thin earnings per share. Analysts forecast meaningful EPS growth ahead.
营收预测 — TAK
1%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $4,581.551B
vs Est $25.852B
▲ 99.4% off
Revenue Trend
Analysts forecast revenue contraction ahead.
